Publications Search

Search for publications by author
Search for publications by abstract keyword(s)

SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer


Pancreatic cancer has a devastating prognosis, with an overall 5-year survival rate of ~8%, restricted treatment options and characteristic molecular heterogeneity. SerpinB2 expression, particularly in the stromal compartment, is associated with reduced metastasis and prolonged survival in pancreatic ductal adenocarcinoma (PDAC) and our genomic analysis revealed that SERPINB2 is frequently deleted in PDAC. We show that SerpinB2 is required by stromal cells for normal collagen remodelling in vitro, regulating fibroblast interaction and engagement with collagen in the contracting matrix. In a pancreatic cancer allograft model, co-injection of PDAC cancer cells and SerpinB2-/- mouse embryonic fibroblasts (MEFs) resulted in increased tumour growth, aberrant remodelling of the extracellular matrix (ECM) and increased local invasion from the primary tumour. These tumours also displayed elevated proteolytic activity of the primary biochemical target of SerpinB2-urokinase plasminogen activator (uPA). In a large cohort of patients with resected PDAC, we show that increasing uPA mRNA expression was significantly associated with poorer survival following pancreatectomy. This study establishes a novel role for SerpinB2 in the stromal compartment in PDAC invasion through regulation of stromal remodelling and highlights the SerpinB2/uPA axis for further investigation as a potential therapeutic target in pancreatic cancer.Oncogene advance online publication, 27 March 2017; doi:10.1038/onc.2017.63.

Type Journal
ISBN 1476-5594 (Electronic) 0950-9232 (Linking)
Authors Harris, N. L.; Vennin, C.; Conway, J. R.; Vine, K. L.; Pinese, M.; Cowley, M. J.; Shearer, R. F.; Lucas, M. C.; Herrmann, D.; Allam, A. H.; Pajic, M.; Morton, J. P.; Australian Pancreatic Cancer Genome, Initiative; Biankin, A. V.; Ranson, M.; Timpson, P.; Saunders, D. N.
Responsible Garvan Author Prof Paul Timpson
Publisher Name ONCOGENE
Published Date 2017-07-27
Published Volume 36
Published Issue 30
Published Pages 4288-4298
Status Published in-print
DOI 10.1038/onc.2017.63
URL link to publisher's version